We value your privacy

We use necessary cookies to make this site work, and Google Analytics to measure visits (it sets cookies and is not affected by the choices below). With your consent, we also use our own analytics cookies to understand how the site is used and improve it. Privacy policy

XOOBAY 数贝环球
金盒集团
金盒集团

金盒集团

Premier Elite

5
Products
0
Followers
2013
Established

Medic Road International, valued at $1 billion, merges with SPAC to officially list on NASDAQ

Medic Road International, valued at $1 billion, merges with SPAC to officially list on NASDAQ

Etao International Group announced: the successful SPAC merger (Special Purpose Acquisition Company) with Mountain Crest Acquisition Corp. III (NASDAQ: MCAE), officially listed on NASDAQ on February 21, 2023, with the stock ticker symbol "ETAO".

Shareholders of Mountain Crest Acquisition Corp. III approved the transaction at a special meeting held on February 7, 2023, and the transaction was also approved by Etao International Group's shareholders.

Upon completion of the transaction, Etao International Group is expected to receive total proceeds of up to $304 million, including a $250 million private investment from China SME Investment Group.

In February 2022, Etao International reached an agreement with Mountain Crest Acquisition Corp. III, at which time the merger transaction was valued at $2.5 billion. This means that Etao International's valuation has decreased by 60% over the course of one year.

As a small-cap stock, Etao International has performed poorly after listing, and as of now, its market capitalization has not reached $1 billion.

Etao International Group (Etao International Group, Cayman) was established in August 2020. In November 2020, "Etao International Medical Technology Co., Ltd." (referred to as Etao China, a wholly-owned subsidiary of Etao International Group) was approved and established.

Through continuous acquisitions of high-quality digital medical institutions, offline hospitals, and digital medical insurance at home and abroad, Etao Group is building a globally leading "medical, pharmaceutical, medical insurance - three medical linkage" digital medical platform that deeply integrates online and offline, technology and services, and maintains the continuous growth of the company's market value in the future.

Currently, Etao Group has more than 3,000 employees and 12 wholly-owned and holding subsidiaries, including three business segments: digital medical care (5 companies), offline medical care (6 companies), and digital medical insurance (1 company). Etao International is strategically benchmarked against Teladoc (the largest digital medical group in the United States) + HCA (the largest hospital group in the world). Etao International has signed letters of intent to acquire 8 high-quality overseas medical assets (1 in Australia, 1 in Canada, and 6 in the United States), and will gradually complete the acquisition and integration after listing.

In September 2022, Quanlian Insurance Brokerage Co., Ltd., a holding subsidiary of Etao International Group, signed a strategic cooperation agreement with Ant Group and Tencent WeSure. The partners will carry out all-round cooperation in technology platforms, promotion and operation, intelligent customer service, health management, special drug supply and claims settlement services, etc.

It is reported that Etao International currently has more than 20 holding units, over 3,000 beds, three internet platforms, nearly 5 million online users, 100 million electronic medical record big data, 3.5 million cancer AI early screening image data, several artificial intelligence medical robots, and more than 3,000 domestic and international doctors and experts.

Wilson, founder and CEO of Etao International Group, said: "Etao International is committed to using the most cutting-edge digital technology to provide better and more affordable healthcare and services for people around the world. The successful listing on NASDAQ is a new starting point for Etao International, and we look forward to bringing more transformative and innovative solutions to the global medical industry."

Dr. Suying Liu, Chairman, Chief Executive Officer and Chief Financial Officer of Mountain Crest, said: “I am very pleased to see the successful completion of another business combination of Mountain Crest’s franchise operations. Medico International is fulfilling its important mission of providing healthcare services to patients in China.”

It is reported that after the completion of the SPAC merger and listing, Medico International will obtain sufficient development funds, continue to acquire high-quality medical institutions online and offline at home and abroad, provide them with comprehensive empowerment such as capital, technology and management, integrate resources to build a globally leading digital healthcare platform with digital medicine as the core, domestic and international chain specialized hospitals as the foundation, and digital pharmaceuticals and digital medical insurance as the two-wheel drive, and deeply integrate online and offline, technology and services.

Originally published on 金盒企业管理集团